Benzinga·2025-12-12 07:45Core Viewpoint - cbdMD Inc. has regained full compliance with NYSE American listing standards, resulting in a significant increase in its stock price by 54.64% in after-hours trading, reaching $0.98 from a previous close of $0.63 [1][2]. Group 1: Compliance and Listing Status - The NYSE American removed cbdMD's ".BC" noncompliant issuer label, indicating that deficiencies related to shareholders' equity and net loss requirements have been resolved [2]. - The company remains subject to NYSE American's continued listing monitoring procedures, emphasizing its commitment to strong financial discipline and governance [3]. Group 2: Financial Strategy and Achievements - The CEO of cbdMD highlighted that regaining the NYSE American listing is a critical achievement, reflecting efforts to strengthen the company's balance sheet through actions such as the Series A preferred share conversion in May and a capital raise in September [4]. - The company has a market capitalization of $5.58 million and has experienced an 80.94% decline in stock price year to date, with a 52-week trading range of $0.47 to $6.54 [5]. Group 3: Trading Metrics - The stock is currently experiencing long-term consolidation with medium and short-term upward movement, as indicated by Benzinga's Edge Stock Rankings [5].